Abstract B017: A sphingolipid-derived paclitaxel nanovesicle enhances efficacy of combination therapies in triple-negative breast cancer and pancreatic cancer
Year: 2026
Type: conference-abstract
Source: Cancer Immunology Research
Author: Jianqin Lu
Institution: University of Arizona
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W7130546130
Cites:
Cited by:
Related to: